Table 2.
Hepatic biological data of a series of 14 patients deceased due to COVID-19 infection
| Patient No. | AST/ALT/GGT at the moment of admission, U/L | AST/ALT/GGT at the moment of death, U/L |
|---|---|---|
| 1 | 98/35/28 | 81/64/32 |
| 2 | 17/10/15 | 9,850/2,500/290 |
| 3 | 35/24/54 | 88/75/103 |
| 4 | 24/17/22 | 15/10/24 |
| 5 | 77/46/108 | 43/46/105 |
| 6 | 188/62/36 | 169/71/84 |
| 7 | 76/58/179 | 24,176/7,245/180 |
| 8 | 77/39/25 | 1,834/1,777/160 |
| 9 | 15/8/10 | 50/18/52 |
| 10 | 15/7/126 | 44/24/44 |
| 11 | 36/11/18 | 37/15/33 |
| 12 | 38/27/33 | 39/22/64 |
| 13 | 40/23/40 | 77/46/503 |
| 14 | 15/58/22 | 43/46/84 |
AST, aspartate amino transferase; ALT, alanine amino transferase; GGT, gamma glutamyl transferase.